Impact of Differential Vaccine Effectiveness on COVID-19 Hospitalization Cases: Projections for 10 Developed Countries where Booster Vaccines were Recommended

Michael Maschio, Kelly Fust, Amy Lee, Nicolas Van de Velde, Philip O. Buck, Michele A. Kohli
doi: https://doi.org/10.1101/2022.09.26.22280377

Article Information

doi 
https://doi.org/10.1101/2022.09.26.22280377
History 
  • September 27, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Michael Maschio, MSc1,
  2. Kelly Fust, MSc1,
  3. Amy Lee, PhD1,
  4. Nicolas Van de Velde, PhD2,
  5. Philip O. Buck, PhD2 and
  6. Michele A. Kohli, PhD1,*
  1. 1Quadrant Health Economics Inc; 92 Cottonwood Crescent, Cambridge, Ontario, Canada
  2. 2Moderna Inc; 200 Technology Square, Cambridge, MA, United States
  1. ↵*Corresponding author; email: michele.kohli{at}quadrantHE.com
Back to top
Posted September 27, 2022.
Download PDF
Data/Code
Email
Impact of Differential Vaccine Effectiveness on COVID-19 Hospitalization Cases: Projections for 10 Developed Countries where Booster Vaccines were Recommended
Michael Maschio, Kelly Fust, Amy Lee, Nicolas Van de Velde, Philip O. Buck, Michele A. Kohli
medRxiv 2022.09.26.22280377; doi: https://doi.org/10.1101/2022.09.26.22280377
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area